These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33994180)

  • 1. Cell Salvage During Liver Transplantation for Hepatocellular Carcinoma: A Retrospective Analysis of Tumor Recurrence Following Irradiation of the Salvaged Blood.
    Weller A; Seyfried T; Ahrens N; Baier-Kleinhenz L; Schlitt HJ; Peschel G; Graf BM; Sinner B
    Transplant Proc; 2021 Jun; 53(5):1639-1644. PubMed ID: 33994180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma.
    Han S; Kim G; Ko JS; Sinn DH; Yang JD; Joh JW; Lee SK; Gwak MS
    Ann Surg; 2016 Aug; 264(2):339-43. PubMed ID: 26501715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
    Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
    World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.
    Welling TH; Eddinger K; Carrier K; Zhu D; Kleaveland T; Moore DE; Schaubel DE; Abt PL
    Liver Transpl; 2018 Sep; 24(9):1233-1242. PubMed ID: 29729113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma.
    Pinto MA; Grezzana-Filho TJM; Chedid AD; Leipnitz I; Prediger JE; Alvares-da-Silva MR; de Araújo A; Zahler S; Lopes BB; Giampaoli ÂZD; Kruel CRP; Chedid MF
    Langenbecks Arch Surg; 2021 Feb; 406(1):67-74. PubMed ID: 33025077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience.
    Zhou J; Fan J; Wang Z; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Sun J; Xiao YS; He YF; Wang YQ; Tang ZY
    World J Gastroenterol; 2006 May; 12(19):3114-8. PubMed ID: 16718799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
    Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM
    J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
    Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
    Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
    Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients.
    Zhai B; Sun XY
    World J Gastroenterol; 2013 Jun; 19(22):3371-4. PubMed ID: 23801828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
    Pei F; Zheng J; Du J; Zhong HH; Yang JP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells.
    Liang TB; Li DL; Liang L; Li JJ; Bai XL; Yu W; Wang WL; Shen Y; Zhang M; Zheng SS
    Transplantation; 2008 Mar; 85(6):863-9. PubMed ID: 18360269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
    Teixeira AC; Mente ED; Castro-e-Silva O; Sankarankutty AK; Cantão CA; Souza FF; Abud D; Muglia V; Elias-Junior J; Martinelli AL
    Transplant Proc; 2010 Mar; 42(2):502-4. PubMed ID: 20304177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.